Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study;Orale Verabreichung von Rinder-Laktoferrin zur Behandlung von Tinea pedis. Ein Plazebo-kontrollierter Doppelblindversuch

Mycoses

Volumn 43, Issue 5, 2000, Pages 197-202

  Yamauchi, ^a,b,c   Hiruma, ^a,b,c   Yamazaki, ^a,b,c   Wakabayashi, ^a,b,c   Kuwata, ^a,b,c   Teraguchi, ^a,b,c   Hayasawa, ^a,b,c   Suegara, ^a,b,c   Yamaguchi, ^a,b,c  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Lactoferrin; Oral administration; Tinea pedis

Indexed keywords

LACTOFERRIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGUS CULTURE; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN MANIFESTATION; TINEA PEDIS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ADMINISTRATION, ORAL; ADULT; ANIMALS; CATTLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; TINEA PEDIS; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; BOVINAE; FUNGI; TINEA; TRICHOPHYTON RUBRUM;

EID: 0033869121     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2000.00571.x     Document Type: Article

References (12)

1. Lactoferrin: Molecular structure and biological function
2. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats
3. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane
4. The bacteriostatic effects of orally administered bovine lactoferrin on intestinal Enterobacteriaceae of SPF mice fed bovine milk
5. Orally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk
6. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats
7. Defensive effect of orally administered bovine lactoferrin against Cryptocaryon irritans infection of red sea bream
8. In vitro susceptibility of candida species to lactoferrin
9. In vitro and in vivo activities of lactoferrin against dermatophytes, with special respect to the effect of orally administered lactoferrin in the guinea pig model of dermatophytosis
10. Itraconazole for the treatment of tinea pedis: A dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2-4 weeks
11. Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity
12. Immune response in skin lesions of dermatophytosis